资讯
Taladegib has been granted orphan drug designation in the U.S. and the European Union as a treatment for idiopathic pulmonary ...
Columnist Sam Kirton had to make some adjustments after his IPF diagnosis, but there are still plenty of ways to find joy, he says.
GRI-0621, an experimental oral therapy for IPF, has so far been tolerated well in an ongoing Phase 2 clinical trial.
Columnist Sam Kirton marks four years since his bilateral lung transplant by reflecting on his health, his family, and his ...
A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary fibrosis.
Clinical trials are an important part of IPF research, says columnist Sam Kirton, but we need people willing to participate in them.
Living with pulmonary fibrosis, columnist Ann Reynoso writes, means no more independent, spontaneous days with enough energy for everything.
In CORAL, 165 IPF patients were given one of three doses of nalbuphine ER to test its ability to reduce cough frequency after six weeks.
Nerandomilast slowed lung function decline in people with IPF and PPF after a year of treatment, according to data from two clinical trials.
A Phase 2 clinical trial has begun recruiting that’s assessing the safety and efficacy of LTI-03, Rein Therapeutics ’ inhaled therapy for idiopathic pulmonary fibrosis (IPF).
The Center for Regenerative Medicine (CReM) of Boston University and Boston Medical Center will collaborate with GSK to develop stem cell-based models to better understand pulmonary fibrosis and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果